Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-13-035295
Filing Date
2013-06-17
Accepted
2013-06-17 18:20:23
Documents
1
Period of Report
2013-06-03

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v347874_3.html 3  
1 OWNERSHIP DOCUMENT v347874_3.xml 3 2557
  Complete submission text file 0001144204-13-035295.txt   4230
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Issuer) CIK: 0000771856 (see all company filings)

EIN.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 702 OGDEN AVE TEANECK NJ 07666
Business Address
MILLER DAVID BARRY (Reporting) CIK: 0001578847 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-17263 | Film No.: 13917782